
Action: Startups Race To Capture The AI Video Generation Market
Making video with AI
Investors can't get enough of start-up artificial intelligence (AI) video generators. Data from Tracxn suggests these businesses have already raised more than $500 million of new funding in 2025 – more than in any previous year. The biggest rounds have included a $308 million raise from New York-based Runway and London-headquartered Synthesia's $180 million investment. And now California's Hedra is joining the party.
Hedra, founded in San Francisco in 2024, will today announce it has raised $32 million of new finance from investors led by a16z Infra, with existing investors including a16z speedrun, Abstract and Index Ventures also participating. This round brings the total amount of money raised by the company to $43 million.
Investors' appetite for the growing number of young businesses in the space reflects the rapid growth in the market, itself a reflection of the pace at which AI video technology is advancing. Allied Market Research estimates the global market for these ventures was worth around $600 million in 2023 – but predicts that this figure will rise to $9.3 billion by 2033. That represents annual growth of more than 30% a year.
The key is to make it as easy as possible to create AI video so that you capture a wider base of customers, says Michael Lingelbach, the founder and CEO of Hedra. In particular, he expects there to be huge demand from enterprises looking to create AI video for brand-building and marketing activity; these firms will need workflow tools that make the process of creation easy, as well as a high-quality output.
'Video AI has huge advantages for enterprise,' Lingelbach says. 'They can get content out very rapidly to capture market moments or cultural references; they can iterate content fast, to test which video performs best, say, or to produce video for multiple local markets in multiple languages, and they can create content that really engages their audiences.'
This is an emerging trend. Until relatively recently, AI video was largely the preserve of enthusiastic individual creators, often producing content with the aim of going viral on social media platforms. Hedra, for example, says 2.5 million users have already used its technology to make such videos.
More recently, however, enterprises have begun to see the potential of this medium, particularly as quality has improved. Many platforms only allow you to make short clips with no sound, but the latest models are far more expansive. Hedra, founded in 2024, launched the latest version of its model, dubbed Character-3, earlier this year, and Lingelback says it has already seen significant interest from enterprise users.
Matt Bornstein, partner at Andreessen Horowitz, the investment firm behind a16z Infra, argues that Hedra's latest model is a significant step forward for the sector, offering the opportunity to make broader content that solutions focused more narrowly on avatars or specific use cases.
'Character-3 is a breakthrough model that integrates text, video and audio to create highly controllable, expressive characters,' he says. 'If you want to create AI-driven actors, it's the best model in the market by far.'
Rival providers will naturally make similar claims for their own platforms – and there is no doubt that the sector now faces something of an arms race. This year's spate of fund raising reflects the need for significant investment in product development and engineering teams as firms vie for market share. The threat of big tech also looms large – OpenAI and Adobe have already launched video generators while Google and Meta have projects in development.
The race is on. "This new investment will help us develop a new generation of AI-powered video experiences that are interactive, real-time, and personalised,' said Victor Riparbelli, CEO and co-founder of Synthesia, when it announced its fund raising earlier this year. '[That offers] possibilities we could have only imagined when we founded the company in 2017.'
At Runway, CEO Cristóbal Valenzuela made a similar point when unveiling its funding round last month, pointing to the progress made with its newly released Gen-4 mode. 'These advancements aren't merely incremental improvements; they form the foundation for an entirely new approach to media,' he said.
For now, with so many players now scaling at pace, it's difficult to call the likely winners. Investors, certainly, are hedging their bets. Still, for the AI video sector as a whole, the future looks bright, with a new generation of platforms making it more straightforward than ever before for everyone from individual users to large enterprises to produce high-quality content.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
an hour ago
- Yahoo
Graham Corporation To Participate in Upcoming Investor Conferences
BATAVIA, N.Y., June 05, 2025--(BUSINESS WIRE)--Graham Corporation (NYSE: GHM) ("GHM" or the "Company"), a global leader in the design and manufacture of mission critical fluid, power, heat transfer and vacuum technologies for the defense, space, energy, and process industries, today announced that Matthew J. Malone, President and Chief Executive Officer, Christopher J. Thome, Vice President - Finance and CFO, will participate at the following upcoming investor conferences: Wells Fargo 2025 Industrials ConferenceDate: Thursday, June 12, 2025Location: Chicago, ILPresentation Time: 1:45 pm ETLive Webcast Link: Here Northland Growth ConferenceDate: Wednesday, June 25, 2025Location: VirtualPresentation Time: 1x1 Meetings Only Interested investors should contact their sales representative to register and schedule one-on-one or group meetings. A live webcast of the presentation, along with presentation materials, will be available at the Events & Presentation section of the Company's investor relations website at About Graham CorporationGraham is a global leader in the design and manufacture of mission critical fluid, power, heat transfer and vacuum technologies for the defense, space, energy, and process industries. Graham Corporation and its family of global brands are built upon world-renowned engineering expertise in vacuum and heat transfer, cryogenic pumps, and turbomachinery technologies, as well as its responsive and flexible service and the unsurpassed quality customers have come to expect from the Company's products and systems. Graham Corporation routinely posts news and other important information on its website, where additional information on Graham Corporation and its businesses can be found. View source version on Contacts For more information, contact: Christopher J. ThomeVice President - Finance and CFOPhone: (585) 343-2216 Tom CookInvestor Relations(203) Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
an hour ago
- Yahoo
SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy
VANCOUVER, British Columbia & TOKYO & WALTHAM, Mass., June 08, 2025--(BUSINESS WIRE)--SOLVE FSHD, a venture philanthropy organization dedicated to accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD), and Modalis Therapeutics Corporation (TSE 4883; "Modalis"), a CRISPR-based epigenome editing therapeutics company focused on rare genetic diseases, today announced a strategic collaboration to develop an innovative therapy for FSHD, a debilitating muscular disorder affecting approximately 1 million individuals worldwide. The novel therapy leverages Modalis's proprietary CRISPR-GNDM® (Guide Nucleotide-Directed Modulation) technology, which can dynamically modulate gene expression without introducing double-strand DNA breaks. SOLVE FSHD will provide strategic funding to support the development of Modalis's MDL-103 program. MDL-103 is an innovative therapeutic solution that continuously suppresses the expression of the DUX4 gene, the toxic disease-causing gene for FSHD, which becomes abnormally activated due to epigenetic changes in the D4Z4 repeat region on chromosome 4. MDL-103 is designed to have durable activity over long periods of time under the control of a strong, muscle-specific promoter, and is delivered to the muscles of patients using a muscle-tropic AAV delivery system. Modalis's CRISPR-GNDM® technology has the potential to transform the treatment of FSHD by epigenetically silencing the expression of DUX4. "SOLVE FSHD is pleased to partner with Modalis and to add them to our diverse portfolio of collaborators that are advancing potential therapies for FSHD," stated Eva Chin, Executive Director of SOLVE FSHD. "SOLVE FSHD identified Modalis as a company committed to finding a cure for this debilitating condition. We were impressed by their unique approach to targeting the epigenetic cause of FSHD, using a platform technology that has shown promise in other neuromuscular diseases. We believe that the support from SOLVE FSHD will allow Modalis to accelerate the advancement of MDL-103 into clinical trials." "We are delighted to be working in partnership with SOLVE FSHD and greatly appreciate the invaluable support for the development of MDL-103," said Haru Morita, CEO of Modalis. "This strategic collaboration is a strong validation of Modalis's CRISPR-GNDM® technology and our MDL-103 program. As a pioneer in this technology, we have demonstrated promising long-term drug efficacy in mouse models, shown durable target engagement and safety in non-human primates, and exhibited excellent biodistribution in neuromuscular disorders. We believe that MDL-103, which incorporates CRISPR-GNDM® technology with a muscle tropic AAV delivery system, has significant potential as a breakthrough treatment for FSHD." About SOLVE FSHD SOLVE FSHD is a venture philanthropic organization established to catalyze innovation and accelerate key research in finding a cure for FSHD. Established by renowned Canadian entrepreneur and philanthropist, Chip Wilson, the Wilson family has committed $100 million to kick-start funding into projects that support the organizations' mission to solve FSHD by 2027. The goal of SOLVE FSHD is to find a solution that can slow down or stop muscle degeneration, increase muscle regeneration and strength, and improve the quality of life for those living with FSHD, visit About Modalis Therapeutics Corporation Modalis was founded in 2016 and conducts research and development activities in Massachusetts, USA. Modalis is a pioneering leader in the field of epigenetic medicine. Modalis develops therapeutics for patients suffering from serious genetic disorders such as neuromuscular diseases, CNS diseases, and cardiomyopathies. Modalis's proprietary CRISPR-GNDM® technology is capable of specifically up or down modulating the expression of disease-relevant genes without introducing double-strand DNA breaks. For more information, visit View source version on Contacts SOLVE FSHDAlexandra Grant, House of Wilsonalexandrag@ Modalis Therapeutics CorporationCorporate Planning Departmentmedia@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Bloomberg
an hour ago
- Bloomberg
Sam Altman's Eyeball-Scanning Identification Tech Expands to UK
Tools for Humanity, a startup co-founded by OpenAI 's Sam Altman, is rolling out its eyeball-scanning Orb devices to the UK as part of a global expansion of the company's novel identification services. Starting this week, people in London, Manchester, Birmingham, Cardiff, Belfast and Glasgow will be able to scan their eyes using Tools for Humanity's proprietary orb device, the company said in a statement on Monday.